Anbenitamab Not Yet Recruiting Phase 2 Trials for HER2-positive Locally Advanced Resectable Gastric Cancer Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT06023758Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC